Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TAZEMETOSTAT HYDROBROMIDE Cause Abdominal pain upper? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Abdominal pain upper have been filed in association with TAZEMETOSTAT HYDROBROMIDE (TAZVERIK). This represents 2.1% of all adverse event reports for TAZEMETOSTAT HYDROBROMIDE.

28
Reports of Abdominal pain upper with TAZEMETOSTAT HYDROBROMIDE
2.1%
of all TAZEMETOSTAT HYDROBROMIDE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Abdominal pain upper From TAZEMETOSTAT HYDROBROMIDE?

Of the 28 reports, 1 (3.6%) resulted in death, 1 (3.6%) required hospitalization.

Is Abdominal pain upper Listed in the Official Label?

Yes, Abdominal pain upper is listed as a known adverse reaction in the official FDA drug label for TAZEMETOSTAT HYDROBROMIDE.

What Other Side Effects Does TAZEMETOSTAT HYDROBROMIDE Cause?

Off label use (298) Fatigue (292) Disease progression (267) Nausea (207) Product dose omission issue (183) Death (106) Diarrhoea (100) Decreased appetite (81) Asthenia (75) Vomiting (75)

What Other Drugs Cause Abdominal pain upper?

ADALIMUMAB (7,337) METHOTREXATE (5,096) ETANERCEPT (4,570) APREMILAST (4,404) TOFACITINIB (4,225) ACETAMINOPHEN (3,879) TOCILIZUMAB (3,876) LEFLUNOMIDE (3,390) ABATACEPT (3,365) NAPROXEN (3,265)

Which TAZEMETOSTAT HYDROBROMIDE Alternatives Have Lower Abdominal pain upper Risk?

TAZEMETOSTAT HYDROBROMIDE vs TAZOBACTAM TAZEMETOSTAT HYDROBROMIDE vs TBO-FILGRASTIM TAZEMETOSTAT HYDROBROMIDE vs TEBENTAFUSP-TEBN TAZEMETOSTAT HYDROBROMIDE vs TECFIDERA TAZEMETOSTAT HYDROBROMIDE vs TECHNETIUM TC-99M

Related Pages

TAZEMETOSTAT HYDROBROMIDE Full Profile All Abdominal pain upper Reports All Drugs Causing Abdominal pain upper TAZEMETOSTAT HYDROBROMIDE Demographics